| 產(chǎn)品名稱 |
Vaccinia virus |
| 商品貨號 |
B193376 |
| Classification |
Poxviridae, Orthopoxvirus |
| Deposited As |
Vaccinia virus, Orthopoxvirus |
| Agent |
Vaccinia virus |
| Strain |
AS |
| Applications |
Vaccination recommended for lab staff manipulating vaccinia, monkeypox, or cowpox viruses (CDC/NIH Biosafety in Microbiological and Biomedical Laboratories, 4th ed, 1999 - stock no. |
| Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation |
Dairen I strain of vaccinia virus that had been used for production of smallpox vaccine at the Government Institute for Infectious D |
| Product Format |
freeze-dried |
| Storage Conditions |
-60°C or colder |
| Disclosure |
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC. |
| Comments |
This is a non-neurotropic strain. Vaccination recommended for lab staff manipulating vaccinia, monkeypox, or cowpox viruses (CDC/NIH Biosafety in Microbiological and Biomedical Laboratories, 4th ed, 1999 - stock no. 017-040-00547-4). Unneurotropic. |
| Effect on Host |
causes pocks on chorioallantoic membranes death of embryos |
| Recommended Host |
chicken embryo, chorioallantoic membrane inoculation chicken embryo; chicken embryo fibroblasts in tissue culture; mouse kidney cells |
| Growth Conditions |
Temperature: 37°C Incubation: 2 days |
| Name of Depositor |
S Arakawa |
| U.S. Patent |
|
| U.S. Patent Number |
|
| Source |
Dairen I strain of vaccinia virus that had been used for production of smallpox vaccine at the Government Institute for Infectious D |
| References |
. Strains of Human Viruses. New York: S Karger; 1972.
|
